Researchers have discovered that two drugs might be better than one for women who have advanced endometrial cancer. Combining chemotherapy and immunotherapy or a monoclonal antibody at the same time helped these patients live longer without their cancer progressing, especially those who had a specific type of endometrial cancer known as a mismatch repair-deficient tumor.… read on > read on >







